Hemodynamic Effects of Variations in Net Ultrafiltration Rate During Continuous Renal Replacement Therapy.
NEPTUNE
Evaluation of the Hemodynamic Effect of Variations in Net Ultrafiltration Rate During Continuous Renal Replacement Therapy Sessions for Acute Renal Failure in Intensive Care Patients. Multiple N-of-1 Randomised Bi-centric Controlled Trial.
1 other identifier
interventional
39
1 country
1
Brief Summary
Net ultra filtration (NUF) is one of the most important parameters during renal replacement therapy (RRT) whose role is to control fluid balance by water removal. To our knowledge, there are no prospective studies or guidelines about the setting of this parameter. In the NEPTUNE study, we aim to compare the hemodynamic effect of three NUF rates during RRT: 1 ml/kg/h, 2 ml/kg/h and 3 ml/kg/h. The research hypothesis is that one of the three flow rates evaluated induces the fewest hemodynamic instabilities related to RRT, while guaranteeing the best possible fluid balance.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 19, 2023
CompletedFirst Posted
Study publicly available on registry
October 6, 2023
CompletedStudy Start
First participant enrolled
October 6, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 8, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
July 8, 2025
CompletedNovember 17, 2025
July 1, 2025
1.8 years
September 19, 2023
November 14, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Occurrence of HIRRT
Occurrence of Hemodynamic Instability related to Renal Replacement Therapy
6 hours
Secondary Outcomes (18)
Number of HIRRT
6 hours
Water depletion
6 hours
Fluid intake
6 hours
Time before HIRRT in each session
6 hours
Time between start of RRT and HIRRT
28 days
- +13 more secondary outcomes
Study Arms (3)
1 ml/kg/h
EXPERIMENTALNet ultra filtration setting: 1 ml/kg/h
2 ml/kg/h
EXPERIMENTALNet ultra filtration setting: 2 ml/kg/h
3 ml/kg/h
EXPERIMENTALNet ultra filtration setting: 3 ml/kg/h
Interventions
The net ultra filtration rate is modified every 6 hours accordingly to randomisation
Eligibility Criteria
You may qualify if:
- Patients hospitalised in the intensive care unit of one of the two participating centres
- Patients with Kidney Disease: Improving Global Outcomes 3 (KDIGO3) acute kidney injury (AKI) requiring a continuous RRT during their stay in the intensive care unit, regardless of the aetiology of the AKI
- Need to prescribe water loss by net ultrafiltration (NUF), defined by at least one of the following sub-criteria:
- weight gain ≥ 1 kg relative to entry weight
- oligo-anuria ≥ 24 hours
- clinical impact of fluid overload as judged by the clinician: acute lung oedema clinical or at CT-scan, difficulty of weaning from mechanical ventilation.
- Hemodynamic stability in the 2 hours preceding the start of NUF, defined by all of the following sub-criteria:
- absence of vasopressors (noradrenaline) or stability or reduction in their dosage
- no need for resuscitative fluids as judged by the clinician
- Patient or his/her trusted support person/legal representative/family member having given free and informed consent, and having signed the consent form or patient included in an emergency situation.
- Patient affiliated to or benefiting from a health insurance scheme.
You may not qualify if:
- Patient moribund, with life expectancy too low to benefit from treatment, or with decision to discontinue treatment
- Patient participating in an another interventional study
- Patient under court protection or guardianship
- Patient/trusted person/legal representative/family member for whom it is impossible to give informed information.
- Pregnant, parturient or breast-feeding patient.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Centre Hospitalier Universitaire de Nîmes
Nîmes, France
Related Publications (4)
Hoste EA, Bagshaw SM, Bellomo R, Cely CM, Colman R, Cruz DN, Edipidis K, Forni LG, Gomersall CD, Govil D, Honore PM, Joannes-Boyau O, Joannidis M, Korhonen AM, Lavrentieva A, Mehta RL, Palevsky P, Roessler E, Ronco C, Uchino S, Vazquez JA, Vidal Andrade E, Webb S, Kellum JA. Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study. Intensive Care Med. 2015 Aug;41(8):1411-23. doi: 10.1007/s00134-015-3934-7. Epub 2015 Jul 11.
PMID: 26162677BACKGROUNDMurugan R, Balakumar V, Kerti SJ, Priyanka P, Chang CH, Clermont G, Bellomo R, Palevsky PM, Kellum JA. Net ultrafiltration intensity and mortality in critically ill patients with fluid overload. Crit Care. 2018 Sep 24;22(1):223. doi: 10.1186/s13054-018-2163-1.
PMID: 30244678BACKGROUNDSharma S, Waikar SS. Intradialytic hypotension in acute kidney injury requiring renal replacement therapy. Semin Dial. 2017 Nov;30(6):553-558. doi: 10.1111/sdi.12630. Epub 2017 Jun 30.
PMID: 28666082BACKGROUNDMurugan R, Kerti SJ, Chang CH, Gallagher M, Neto AS, Clermont G, Ronco C, Palevsky PM, Kellum JA, Bellomo R. Association between Net Ultrafiltration Rate and Renal Recovery among Critically Ill Adults with Acute Kidney Injury Receiving Continuous Renal Replacement Therapy: An Observational Cohort Study. Blood Purif. 2022;51(5):397-409. doi: 10.1159/000517281. Epub 2021 Jul 21.
PMID: 34289471BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Saber D. BARBAR, MD, PhD
Centre Hospitalier Universitaire de Nīmes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 19, 2023
First Posted
October 6, 2023
Study Start
October 6, 2023
Primary Completion
July 8, 2025
Study Completion
July 8, 2025
Last Updated
November 17, 2025
Record last verified: 2025-07